Respinor
About[edit]
Respinor AS is a Norwegian medical technology company developing non-invasive ultrasound-based monitoring solutions for diaphragm function. Founded in 2015 with 9 employees.
Product[edit]
DXT[edit]
DXT is a novel, non-invasive ultrasound device for diaphragm monitoring. Key features:
- Non-invasive ultrasound-based technology
- Accurate and continuous diaphragm monitoring
- Enables early detection of diaphragm dysfunction
- Designed for critical care settings
- Successfully validated in clinical studies on mechanically ventilated patients
Clinical Need[edit]
Diaphragm dysfunction in critically ill patients is associated with:
- Increased mortality in ICU
- Prolonged mechanical ventilation
- Difficult weaning from ventilators
- Increased healthcare costs
Currently, monitoring diaphragm function in ICU patients is challenging. DXT addresses this with a non-invasive approach that can detect dysfunction early.
Market[edit]
Critical care monitoring represents a significant market. Diaphragm ultrasound is an emerging standard of care, and a dedicated device for continuous monitoring could address a growing clinical need as ICU awareness of diaphragm dysfunction increases.